CSBR:NASDAQ
Champions Oncology Inc
USD 4,58
arrow_downward
-0,25%(-0,012) 1D
18 Nov., 12:11:23 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
USD 4,55
High
USD 4,60
Low
USD 4,41
Mkt. cap
63,77 m
Avg. vol.
7,41 k
Volume
7,69 k
52-wk high
USD 8,31
52-wk low
USD 4,41
EPS
-USD 0,08
Beta
0,47
Shares outstanding
13,92 m
No. of employees
217
Open
USD 4,55
High
USD 4,60
Low
USD 4,41
Mkt. cap
63,77 m
Avg. vol.
7,41 k
Volume
7,69 k
52-wk high
USD 8,31
52-wk low
USD 4,41
EPS
-USD 0,08
Beta
0,47
Shares outstanding
13,92 m
No. of employees
217
News stories
From web sources and news partners
Yahoo Finance
·
3 uur gelede
Investors Love the S&P 500 Index. Here’s Why I Don’t.
Hedgeye
·
3 uur gelede
Why Negative Gamma Has Taken the Brakes Off the S&P 500
Talking Biz News
·
7 minute gelede
Dow Jones News Fund names four to board
Barron's
·
4 uur gelede
S&P 500 Futures Rise in Premarket Trading; Global-E Online, STAG Industrial Lag
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, Verenigde State van Amerika
SectorHealth Care
Industry-
Websitechampionsoncology.com